DNA Could Thwart Trade of the World’s Most Trafficked Mammal

Pangolins are poached for their scales and meat, leading researchers to develop a set of molecular tools to help track and mitigate the trade.

Written byDiana Kwon
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM,
DARRENBRADLEYPHOTOGRAPHY

Growing to more than 1.5 meters and weighing in at up to 75 pounds, pangolins aren’t meager creatures. They are solitary, insect-eating mammals that come in a range of sizes, yet all are wrapped in a distinctive armor of sharp, brownish scales. Sometimes referred to as “scaly anteaters” due to their diet and appearance, pangolins have recently attracted global attention for their potential role in the ongoing COVID-19 pandemic. The source of SARS-CoV-2, the virus that causes COVID-19, remains unclear, but scientists suspect the coronavirus originated in bats and passed to people via an intermediate host. That intermediate host may have been the pangolin, some studies suggest.

The possible role of pangolins in the new coronavirus outbreak has recently piqued the interest of scientists around the world. But many researchers have been studying pangolins for years, for another reason: the scaly creatures are the most trafficked mammals ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies